Beta Bionics
BBNX
130 hedge funds and large institutions have $495M invested in Beta Bionics in 2026 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 47 reducing their positions, and 47 closing their positions.
3.88% more ownership
Funds ownership: 107.26% → 111.13% (+3.9%)
0% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 47
18% less funds holding
Funds holding: 158 → 130 (-28)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
49% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 47
66% less capital invested
Capital invested by funds: $1.44B → $495M (-$944M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$26.9M |
| 2 |
VPC
Vestal Point Capital
New York
|
+$23.8M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$22.7M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$14.1M |
| 5 |
Morgan Stanley
New York
|
+$11.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$29.2M |
| 2 |
Walleye Capital
New York
|
-$19.7M |
| 3 |
1WCM
12 West Capital Management
New York
|
-$17.5M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$13.1M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$11.6M |
BBNX Hedge Fund Activity: Q1 2026 in Review
130 of the 8,129 institutional investors tracked by Wall St. Rank reported a position in Beta Bionics (BBNX) for Q1 2026, worth a combined $495M — down 66% from $1.44B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of BBNX and 24 opened new positions — a net loss of 23 holders — while 47 trimmed existing stakes and 47 added.
The largest buyer was Soleus Capital Management, adding an estimated $26.9M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $29.2M sold.
- 130 institutional investors held Beta Bionics (BBNX) as of Q1 2026, down from 158 in Q4 2025.
- Funds reported $495M of Beta Bionics stock for Q1 2026, down 66% quarter-over-quarter.
- 24 funds opened new Beta Bionics positions in Q1 2026 and 47 closed out, a net change of -23 holders.
- The largest Beta Bionics buyer in Q1 2026 was Soleus Capital Management, an estimated $26.9M added.
- The largest Beta Bionics seller in Q1 2026 was Driehaus Capital Management, an estimated $29.2M sold.
Based on aggregated 13F filings for Q1 2026.